Abfero Pharmaceuticals

Developer of oral iron chelators for the treatment of iron overload diseases

placeBoston, Massachusetts, United States calendar_todayFounded 2016 groups3 employees language abferopharmaceuticals.com

Registered entities

Innovation

1 patent family (1 granted) — focus: Human necessities; filing pace accelerating. Cited 53 times.

YearFilings
20181
20191
20201
20211
20231
20241
20251
20261

Investor mix

4 investors on record; lead investors include Eureka.

Investor typeCountShare
Venture capital125%
Other / undisclosed375%
Coming soon